The Deep End by ODF cover image

"The most important milestone in the history of longevity biotech" — Archival Interview with Celine Halioua (Founder/CEO of Loyal)

The Deep End by ODF

CHAPTER

The Build-to-Buy Model in the Biotech Industry

Exploring how biotech companies use the build-to-buy model to make profitable exits by selling their drug assets to established pharmaceutical companies.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner